Background illustration for clinical trials search

Paid Clinical Trials Plainfield

Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,367

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,

Location: Naperville IL, Evanston IL, Janesville WI, Madison WI,

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

Hyrax Vs. Invisalign Palatal Expander Clinical Study

for

Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding

Location: Naperville IL, Chevy Chase MD, Warner Robins GA,

Sponsor: Align Technology, Inc.

Sex: All

Age: 6 - 11

Code: NCT06662279

Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for

Solid Tumors

Location: Naperville IL, Madison WI, Springfield IL,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Location: New Lenox IL, Glenview IL, Merrillville IN, Carmel IN,

Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

for

Metastatic Solid Tumor, Advanced Solid Tumor,

Location: New Lenox IL, Milwaukee WI, Columbus OH, Nashville TN,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06561685

Phase1, Recruiting

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

for

Aortic Stenosis, Severe

Location: New Lenox IL, Elk Grove Village IL, Evanston IL,

Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT05172960

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,

Location: New Lenox IL, Orland Park IL, Chicago IL, Munster IN,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

for

Recurrent B-Cell Non-Hodgkin Lymphoma,

Location: New Lenox IL, Orland Park IL, Chicago IL, New York NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05272384

Phase1, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: New Lenox IL, Warrenville IL, Orland Park IL, Geneva IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

for

HER2-positive Breast Cancer, Metastatic Cancer,

Location: New Lenox IL, Orland Park IL, Chicago IL,

Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT05868226

Phase1, Phase2, Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for

Advanced Lung Neuroendocrine Tumor,

Location: New Lenox IL, Orland Park IL, Chicago IL, St Louis MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase2, Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

for

Metastatic Digestive System Neuroendocrine Tumor G1,

Location: New Lenox IL, Warrenville IL, Orland Park IL, Geneva IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05773274

Phase2, Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for

Accelerated Phase Myeloproliferative Neoplasm,

Location: New Lenox IL, Orland Park IL, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06661915

Phase2, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for

B Acute Lymphoblastic Leukemia

Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase3, Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,

Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: New Lenox IL, Warrenville IL, Orland Park IL, Geneva IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for

Advanced Hepatocellular Carcinoma,

Location: New Lenox IL, Orland Park IL, Chicago IL,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for

Advanced Malignant Solid Neoplasm,

Location: New Lenox IL, Warrenville IL, Downers Grove IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia,

Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: New Lenox IL, Orland Park IL, Maywood IL, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Paid Clinical Trials Plainfield

Filter results

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Hyrax Vs. Invisalign Palatal Expander Clinical Study

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Interested in new trials?

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

PRE-ISPY Phase I/II Oncology Platform Program

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)